血管性痴呆:治療薬の治験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Vascular Dementias Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vascular Dementias 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Vascular Dementias to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Vascular Dementias to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Vascular Dementias 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Vascular Dementias Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Johnson & Johnson 31
Clinical Trial Overview of Johnson & Johnson 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Janssen-Cilag A.G. 33
Clinical Trial Overview of Janssen-Cilag A.G. 33
Golgi Pharmaceuticals Ltd 34
Clinical Trial Overview of Golgi Pharmaceuticals Ltd 34
EVER Neuro Pharma GmbH 35
Clinical Trial Overview of EVER Neuro Pharma GmbH 35
Eisai Co., Ltd. 36
Clinical Trial Overview of Eisai Co., Ltd. 36
Dr. Willmar Schwabe Pharmaceuticals 37
Clinical Trial Overview of Dr. Willmar Schwabe Pharmaceuticals 37
Diaxonhit S.A. 38
Clinical Trial Overview of Diaxonhit S.A. 38
Clinical Trial Overview of Top Institutes / Government 39
University of Pennsylvania 39
Clinical Trial Overview of University of Pennsylvania 39
Ministry of Education, Culture, Sports, Science and Technology 40
Clinical Trial Overview of Ministry of Education, Culture, Sports, Science and Technology 40
Radboud University 41
Clinical Trial Overview of Radboud University 41
University of Pittsburgh 42
Clinical Trial Overview of University of Pittsburgh 42
Cardiff University 43
Clinical Trial Overview of Cardiff University 43
University of Western Sydney 44
Clinical Trial Overview of University of Western Sydney 44
Chang Gung Memorial Foundation 45
Clinical Trial Overview of Chang Gung Memorial Foundation 45
VU University Medical Center 46
Clinical Trial Overview of VU University Medical Center 46
Samsung Medical Center 47
Clinical Trial Overview of Samsung Medical Center 47
The Sheba Medical Center 48
Clinical Trial Overview of The Sheba Medical Center 48
Five Key Clinical Profiles 49
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69


【レポート販売概要】

■ タイトル:血管性痴呆:治療薬の治験動向(2014年下半期)
■ 英文:Vascular Dementias Global Clinical Trials Review, H2, 2014
■ 発行日:2014年8月12日
■ 調査会社:GlobalData
■ 商品コード:GDHC2297CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。